ARRY - Array BioPharma Stock Trading

Array BioPharma Inc.(NASDAQ: ARRY) stock trading, description, contact, officers and directors.

About Array BioPharma Inc.

Not available

Stock Information

Array BioPharma Inc. Company Name:

ARRY Stock Symbol:

NASDAQ Market:

Array BioPharma Inc. Website:

Get ARRY Alerts

News, Short Squeeze, Breakout and More Instantly...

ARRY - Pharma Trends 2019: FDA Approvals Make Waves Through Sector

With the end of 2019 nearing, the Investing News Network (INN) is looking back on the developments that shaped the pharma industry this past year. Investors watched on as mergers and acquisitions (M&A) flooded the sector, while drug pricing issues continued to play out as the conversatio...
ARRY - Array BioPharma Announces Interim Analysis Results from the BEACON CRC Trial of BRAFTOVI + MEKTOVI + Cetuximab for the Treatment of BRAFV600E-Mutant Metastatic Colorectal Cancer at the ESMO 21st World Congress on Gastrointestinal Cancer

BOULDER, Colo. , July 6, 2019 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced the presentation of results from the Phase 3 BEACON CRC trial evaluating the combination of BRAFTOVI ® (encorafenib), a BRAF inhibitor, MEKTOVI ® (binimetinib), a MEK inhibit...
ARRY - AbbVie to Acquire Allergan in Blockbuster US$63 Billion Deal

AbbVie (NYSE: ABBV ) has added itself to the growing list of pharmaceutical companies making behemoth acquisition announcements so far in 2019. On Tuesday (June 25), the pharmaceutical giant revealed its proposed cash and stock acquisition of Allergan (NYSE: AGN ), worth a whopp...